Multiple Sclerosis Clinical Trial
— OCRISOfficial title:
Evaluation of the Prevalence of Oculomotor Disorders in Patients With Radiologically Isolated Syndrome
Verified date | April 2022 |
Source | Centre Hospitalier Universitaire de Nimes |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to investigate the prevalence of subclinical oculomotor disorders in a population of patients with radiologically isolated syndrome.
Status | Completed |
Enrollment | 61 |
Est. completion date | November 5, 2021 |
Est. primary completion date | October 21, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - The patient must have given his informed consent and signed the consent form. - The patient must be affiliated or beneficiary of a health insurance plan. - The patient is at least 18 years old (=) and under 50 years old (=). - Patients with radiologically isolated syndrome according to the criteria of Okuda et al. (2009) - Diagnosis of a radiologically isolated syndrome confirmed by the national expert center of Nice for less than 3 years. Exclusion Criteria: - The subject participates in another study. - The subject is in an exclusion period determined by a previous study. - The subject is under guardianship, curatorship or safeguard of justice. - The patient is pregnant or breastfeeding - The subject refuses to sign the consent. - It is not possible to give the subject informed information. - Patient presenting a pathological neurological examination. - Patient with visual acuity less than 5/10 or with ocular instability |
Country | Name | City | State |
---|---|---|---|
France | Hôpital Neurologique Pierre Wertheimer | Bron | |
France | Hôpital Guy de Chauliac | Montpellier | |
France | Nice University Hospital | Nice | |
France | Nimes University Hospital | Nîmes | |
France | Pitié Salpêtrière University Hospital (APHP) | Paris | |
France | Toulouse University Hospital | Toulouse |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nimes |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of the occurrence of oculomotor disorders | using a video-oculographic recording system | Day 0 | |
Secondary | To establish the prevalence of each of the different types of oculomotor abnormalities that constitute the oculomotor disorder | number | Day 0 | |
Secondary | To identify a correlation between oculomotor disorders and MRI abnormalities. | Day 0 | ||
Secondary | To identify a correlation between oculomotor disorders and the cognitive impairment test (Symbol Digit Modalities Test) | Day 0 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |